$BIRK

Birkenstock Holding plc

No enriched coverage for $BIRK in the last 7 days.

$1.10B
Chu James Michael
0%
See all $BIRK insider activity →
Low

Michael Burry Bought Beaten-Down Stocks And Shorted AI Favorites — Here’s How His August Bets Fared

Michael Burry, known for his 'Big Short' bet, disclosed August trades including long positions in MercadoLibre (MELI), Zoetis (ZTS), Lululemon (LULU), and Molina Healthcare (MOH), and short positions in Palantir (PLTR), Nvidia (NVDA), and others. Nine of his 17 long holdings rose, with Veeva (VEEV) up 35.8%, while his short bets faced pressure as AI stocks rallied, with Palantir up 51.4%. Burry adjusted his portfolio, raising cash and managing risk.

Burry calls Birkenstock a full position at 30% discount to fair value

Michael Burry increased his stake in Birkenstock (NYSE:BIRK) at a 30% discount to its fair value, according to a Substack post. The company reported Q3 2026 adjusted EPS of EUR 0.74, up 19% YoY, and raised its full-year adjusted EBITDA guidance to at least EUR 710 million. Despite this, the stock fell 9.4% due to a $1 billion equity offering and a $500 million share buyback. Burry's investment thesis is based on the brand's durability and deep-value entry price.

Why is Birkenstock stock surging today?

Birkenstock (BIRK) stock rose 6.6% in pre-market trading, rebounding from near its 52-week low. The surge follows a reassessment of its fundamentals, including Q3 FY2026 revenue of €719.5 million, beating estimates, and raised guidance. Analysts maintain a Strong Buy consensus with targets above current levels, viewing the August sell-off as an overreaction.

BIRK sentiment & insider activity

Recent BIRK coverage spans financial news, market movers and corporate actions.

In the last 30 days, BIRK insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($1.10B). The most active reporter was Chu James Michael with 1 filing.

What's driving BIRK

alphai scores every news story that mentions BIRK with an AI model for sentiment and relevance, and aggregates insider trades from Birkenstock Holding plc's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BIRK

Score

Michael Burry Bought Beaten-Down Stocks And Shorted AI Favorites — Here’s How His August Bets Fared

Michael Burry, known for his 'Big Short' bet, disclosed August trades including long positions in MercadoLibre (MELI), Zoetis (ZTS), Lululemon (LULU), and Molina Healthcare (MOH), and short positions in Palantir (PLTR), Nvidia (NVDA), and others. Nine of his 17 long holdings rose, with Veeva (VEEV) up 35.8%, while his short bets faced pressure as AI stocks rallied, with Palantir up 51.4%. Burry adjusted his portfolio, raising cash and managing risk.

$BIRKLow

Burry calls Birkenstock a full position at 30% discount to fair value

Michael Burry increased his stake in Birkenstock (NYSE:BIRK) at a 30% discount to its fair value, according to a Substack post. The company reported Q3 2026 adjusted EPS of EUR 0.74, up 19% YoY, and raised its full-year adjusted EBITDA guidance to at least EUR 710 million. Despite this, the stock fell 9.4% due to a $1 billion equity offering and a $500 million share buyback. Burry's investment thesis is based on the brand's durability and deep-value entry price.

$BIRKLow

Why is Birkenstock stock surging today?

Birkenstock (BIRK) stock rose 6.6% in pre-market trading, rebounding from near its 52-week low. The surge follows a reassessment of its fundamentals, including Q3 FY2026 revenue of €719.5 million, beating estimates, and raised guidance. Analysts maintain a Strong Buy consensus with targets above current levels, viewing the August sell-off as an overreaction.

$BIRKHighAI 8/10

Birkenstock (BIRK) Q3 2026 Earnings Call Transcript

Birkenstock (BIRK) reported Q3 2026 revenue of EUR 720M, up 15% in constant currency, and raised full-year guidance. Adjusted EBITDA grew 11% to EUR 242M, while adjusted EPS increased 19% to EUR 0.74. DTC sales outpaced B2B for the first time in eight quarters. The company issued EUR 900M in senior notes and repurchased EUR 230M in shares. Management cited strong demand in APAC, particularly China, and noted risks from Middle East conflicts and closed-toe product margin drag.

$BIRKMed

Birkenstock Beats the Skeptics—But Not on EPS

Birkenstock's adjusted EBITDA margin slipped to 33.7% due to FX and tariff headwinds. Operating cash flow was $250M, but net leverage rose to 1.8x. A $1B secondary offering by L Catterton, not Birkenstock, caused a 4% stock drop. Birkenstock's buyback offsets dilution. Analysts rate BIRK a Moderate Buy with a $53.91 target.

Related tickers